Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma - Takeaways - MDSpire

Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma

  • By

  • Ping Huang

  • Fenping Zhang

  • Yuchun Lin

  • Jie Peng

  • Zesong Yang

  • June 10, 2026

  • 0 min

Share

  • 1

    A correction was issued regarding the ethics approval number in the study on multiple myeloma.

  • 2

    The original approval number for the First Affiliated Hospital of Chongqing Medical University was incorrect.

  • 3

    The corrected approval number for the First Affiliated Hospital is CY2025-344-01.

  • 4

    The approval number for Fengdu County Traditional Chinese Medicine Hospital remains FDYY-2025-0303.

  • 5

    Written informed consent was obtained from all participants in the study.

Original Source(s)

Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma

  • by Ping Huang, Fenping Zhang, Yuchun Lin, Jie Peng, Zesong Yang

  • June 10, 2026

Related Content

Evaluating Hypoalbuminemia as a Prognostic Indicator in Monoclonal Gammopathy of Undetermined Significance (MGUS) within Its Biological Framework

Targeting CD38 Enzymatic Function in Antibody-Driven Immunotherapy for Multiple Myeloma: Insights from Basic Research

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma